DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

Reuters06:01

DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump

Feb 2 (Reuters) - DaVita DVA.N projected annual profit above estimates on Monday after reporting better-than-expected fourth-quarter results on steady demand for its kidney dialysis services, sending its shares up 13% in after-hours trading.

The company, which provides dialysis services at outpatient clinics and at home for patients with chronic kidney failure, signaled renewed momentum after dealing with rising patient care and operating costs in recent quarters.

The Colorado-based company now expects its 2026 adjusted profit per share to be between $13.60 and $15. Analysts were expecting it to be $12.65 per share, according to data compiled by LSEG.

Higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines helped lift fourth-quarter profit and revenue above expectations, the company said.

It had been dealing with the fallout from a ransomware attack in April that disrupted parts of its operations and exposed the personal data of 2.7 million people.

On an adjusted basis, it reported a profit of $3.40 per share for the quarter ended December 31, above analysts' estimates of $3.16 per share.

The company reported quarterly revenue of $3.62 billion, compared to analysts' estimates of $3.50 billion.

(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)

((siddhi.mahatole@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2608813599?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-03 06:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2608813599","market":"nz","top_or_hot":-1,"title":"DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump</title></head><body><p>\n<span>Feb 2 (Reuters)</span><span> - </span>DaVita <span>DVA.N</span> projected annual profit above estimates on Monday after reporting better-than-expected fourth-quarter results on steady demand for its kidney dialysis services, sending its shares up 13% in after-hours trading. </p><p>The company, which provides dialysis services at outpatient clinics and at home for patients with chronic kidney failure, signaled renewed momentum after dealing with rising patient care and operating costs in recent quarters.</p><p>The Colorado-based company now expects its 2026 adjusted profit per share to be between $13.60 and $15. Analysts were expecting it to be $12.65 per share, according to data compiled by LSEG. </p><p>Higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines helped lift fourth-quarter profit and revenue above expectations, the company said.</p><p>It had been dealing with the fallout from a <span>ransomware attack in April</span> that disrupted parts of its operations and exposed the personal data of 2.7 million people.</p><p>On an adjusted basis, it reported a profit of $3.40 per share for the quarter ended December 31, above analysts' estimates of $3.16 per share.</p><p>The company reported quarterly revenue of $3.62 billion, compared to analysts' estimates of $3.50 billion.</p><p> (Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)</p><p> ((siddhi.mahatole@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-03 06:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump</title></head><body><p>\n<span>Feb 2 (Reuters)</span><span> - </span>DaVita <span>DVA.N</span> projected annual profit above estimates on Monday after reporting better-than-expected fourth-quarter results on steady demand for its kidney dialysis services, sending its shares up 13% in after-hours trading. </p><p>The company, which provides dialysis services at outpatient clinics and at home for patients with chronic kidney failure, signaled renewed momentum after dealing with rising patient care and operating costs in recent quarters.</p><p>The Colorado-based company now expects its 2026 adjusted profit per share to be between $13.60 and $15. Analysts were expecting it to be $12.65 per share, according to data compiled by LSEG. </p><p>Higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines helped lift fourth-quarter profit and revenue above expectations, the company said.</p><p>It had been dealing with the fallout from a <span>ransomware attack in April</span> that disrupted parts of its operations and exposed the personal data of 2.7 million people.</p><p>On an adjusted basis, it reported a profit of $3.40 per share for the quarter ended December 31, above analysts' estimates of $3.16 per share.</p><p>The company reported quarterly revenue of $3.62 billion, compared to analysts' estimates of $3.50 billion.</p><p> (Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)</p><p> ((siddhi.mahatole@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nL4N3YY1XL:1","article_id":"2608813599","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2608813599","pubTimestamp":1770069706,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Feb 2  - DaVita DVA.N projected annual profit above estimates on Monday after reporting better-than-expected fourth-quarter results on steady demand for its kidney dialysis services, sending its shares up 13% in after-hours trading. The company, which provides dialysis services at outpatient clinics and at home for patients with chronic kidney failure, signaled renewed momentum after dealing with rising patient care and operating costs in recent quarters.The Colorado-based company now expects its 2026 adjusted profit per share to be between $13.60 and $15. Analysts were expecting it to be $12.65 per share, according to data compiled by LSEG. Higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines helped lift fourth-quarter profit and revenue above expectations, the company said.It had been dealing with the fallout from a ransomware attack in April that disrupted parts of its operations and exposed the personal data of 2.7 million people.On an ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健","BK4585":"ETF&股票定投概念","BK4559":"巴菲特持仓","BK4196":"保健护理服务","BK4588":"碎股"},"translate_title":"DaVita预测2026年利润高于预期，透析服务需求稳定；股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":0.9},"content_text":"DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump\nFeb 2 (Reuters) - DaVita DVA.N projected annual profit above estimates on Monday after reporting better-than-expected fourth-quarter results on steady demand for its kidney dialysis services, sending its shares up 13% in after-hours trading. The company, which provides dialysis services at outpatient clinics and at home for patients with chronic kidney failure, signaled renewed momentum after dealing with rising patient care and operating costs in recent quarters.The Colorado-based company now expects its 2026 adjusted profit per share to be between $13.60 and $15. Analysts were expecting it to be $12.65 per share, according to data compiled by LSEG. Higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines helped lift fourth-quarter profit and revenue above expectations, the company said.It had been dealing with the fallout from a ransomware attack in April that disrupted parts of its operations and exposed the personal data of 2.7 million people.On an adjusted basis, it reported a profit of $3.40 per share for the quarter ended December 31, above analysts' estimates of $3.16 per share.The company reported quarterly revenue of $3.62 billion, compared to analysts' estimates of $3.50 billion. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore) ((siddhi.mahatole@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2608813599","isCrawlerRequest":true}